NASDAQ : RDNT
RadNet, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 73.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.78B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.78B |
| Enterprise Value | 7.24B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 78.70M |
| Shares Outstanding | 78.70M |
| Shares Change (YoY) | +3.63% |
| Shares Change (QoQ) | +2.17% |
| Owned by Insiders (%) | 10.26% |
| Owned by Institutions (%) | 98.98% |
| Float | 65.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 147.60 |
| PS Ratio | 2.55 |
| Forward PS | 2.16 |
| PB Ratio | 5.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 79.91 |
| P/OCF Ratio | 18.65 |
| PEG Ratio | 12.30 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.19 |
| EV / EBITDA | 26.22 |
| EV / EBIT | 68.96 |
| EV / FCF | 100.06 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.48 |
| Quick Ratio | 1.39 |
| Debt / Equity | 1.57 |
| Debt / EBITDA | 5.58 |
| Debt / FCF | 30.18 |
| Interest Coverage | 1.30 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.50% |
| Return on Assets (ROA) | 1.70% |
| Return on Invested Capital (ROIC) | 2.04% |
| Return on Capital Employed (ROCE) | 2.98% |
| Weighted Average Cost of Capital (WACC) | 9.28% |
| Revenue Per Employee | $244,602 |
| Profits Per Employee | -$2,276 |
| Employee Count | 9,276 |
| Asset Turnover | 0.59 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 15.71M |
| Effective Tax Rate | 44.90% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -6.79% |
| 50-Day Moving Average | 72.56 |
| 200-Day Moving Average | 65.14 |
| Relative Strength Index (RSI) | 57.90 |
| Average Volume (20 Days) | 496,311 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.06M |
| Short Previous Month | 9.36M |
| Short % of Shares Out | 11.52% |
| Short % of Float | 13.78% |
| Short Ratio (days to cover) | 13.29 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.27B |
| Gross Profit | 392.17M |
| Operating Income | 105.00M |
| Pretax Income | 34.98M |
| Net Income | -21.12M |
| EBITDA | 276.15M |
| EBIT | 105.00M |
| Loss Per Share | -$0.27 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 726.27M |
| Total Debt | 2.18B |
| Net Cash | -1.46B |
| Net Cash Per Share | -$18.52 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 13.94 |
| Working Capital | 337.93M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 310.06M |
| Capital Expenditures | -237.69M |
| Depreciation & Amortization | 171.15M |
| Net Borrowing | 211.96M |
| Free Cash Flow | 72.37M |
| FCF Per Share | $0.92 |
Margins
| Measure | Value |
|---|
| Gross Margin | 17.28% |
| Operating Margin | 4.63% |
| Pretax Margin | 1.54% |
| Profit Margin | -0.93% |
| EBITDA Margin | 12.17% |
| EBIT Margin | 4.63% |
| FCF Margin | 3.19% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.63% |
| Shareholder Yield | -3.63% |
| Earnings Yield | -0.37% |
| FCF Yield | 1.25% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $94.63 |
| Price Target Difference | 28.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 14.87% |
| EPS Growth Forecast (3Y) | 35.95% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 28, 2006 |
| Split Type | Reverse |
| Split Ratio | 1:2 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |